Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2014162613
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2014162613
Title / Product Name
Kombination aus einem Anti-CTLA4-Antikörper mit Etoposide für die synergistische Behandlung proliferativer Erkrankungen
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2014162613
EP Publication Number
2769737
E-Number
881172
Language
EN
PCT Number
-
Publication Date
27.08.2014 A
05.04.2017 B1
Registration Date
05.04.2017
AT Publication Date
15.04.2017
Application Date
29.10.2009
Registration Number
-
Priorities
20.07.2009
US
226910 P
30.07.2009
US
462168
30.07.2009
WO
PCT/US2009/052209
IPC
A61K 45/06 20060101AFI20161103BHEP
Maximum Duration of Protection
29.10.2029
Owner
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543
US
Representative
Representative
Patentanwalt Mikšovsky KG
Bisamberger Straße 19
2100 Korneuburg
AT
Inventor
Lee, Francis, Y.
c/o Bristol-Myers Squibb Company Route 206 & Province Line Road
Princeton, NJ New Jersey 08543
US
Jure-Kunkel, Maria
c/o Bristol-Myers Squibb Company Route 206 & Province Line Road
Princeton, NJ New Jersey 08543
US
Information about Fees
Click here to load the fees
see.ip - Details for Kombination aus einem Anti-CTLA4-Antikörper mit Etoposide für die synergistische Behandlung proliferativer Erkrankungen